Seasonal Affective Disorder Therapeutics Market
Market Insights on Seasonal Affective Disorder Therapeutics covering sales outlook, demand forecast & up-to-date key trends
Seasonal Affective Disorder Therapeutics Market By Treatment Type (Drugs, Devices), Disorder Type (Unipolar Disorders, Bipolar Disorders), Distribution Channel (Institutional Sales, Retail Sales) & Region - Forecast 2022 - 2028
Seasonal Affective Disorder Therapeutics Market Outlook (2022-2028)
[216 Pages] From 2022 to 2028, the global seasonal affective disorder therapeutics market is slated to rise at a CAGR of 4.3%. Currently, the market accounts for a valuation of US$ 848.2 Mn, and is projected to close in on US$ 1.1 Bn by the end of 2028.
|
Seasonal Affective Disorder Therapeutics Market Size (2022) |
US$ 848.2 Mn |
|
Projected Market Value (2028) |
US$ 1.1 Bn |
|
Global Market Growth Rate (2022-2028) |
4.3% CAGR |
|
North America Market Share |
38.4% |
Sales of seasonal affective disorder therapeutic drugs and devices account for a share of 4.6% in the global depressive disorder treatment market. Preference and popularity of bright light therapy among physicians and patients is expected to be a major trend driving seasonal affective disorder therapeutics demand growth through 2028.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
4.29% |
|
H1, 2022 Projected |
4.34% |
|
H1, 2022 Outlook |
4.24% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 05 ↓ |
The market for seasonal affective disorder therapeutics is subject to change as per the regulatory dynamics for drugs, in accordance to macroeconomic and industrial standards.
The variation between the BPS values observed within this market in H1, 2022 - outlook over H1, 2022 projected reflects a decline of 10 BPS units. Additionally, a drop in BPS growth in H1-2022 over H1-2021 by 05 Basis Point Share (BPS) is demonstrated by the market.
The decline in the BPS values is associated with the limited evidence for the effectiveness of light therapy when compared with other available preventive options. Moreover, patient preference towards treatment modalities is dominant for the preventive treatment of seasonal affective disorder.
On the contrary, the market is expected to gain traction in terms of growth and sales outlook during the forecast period. This is supported with the development of second-generation antidepressants for the treatment of seasonal affective disorder in adults.
The key developments in the market include the FDA approval of an extended-release antidepressant, bupropion, for the prevention of recurrent seasonal affective disorder with major depressive episodes.
Demand Survey of Seasonal Affective Disorder Therapeutics (2013 to 2021) Vs Market Statistics (2022 to 2028)
Anxiety and depression among the general population have seen a substantial spike over the past few years and this has majorly influenced the healthcare industry in multiple ways. The seasonal affective disorder therapeutics market exhibited expansion at a CAGR of 3.7% from 2013 to 2021.
Increasing prevalence of seasonal affective disorders, rising instances of depression among the general population, increasing availability of treatment options, and rising research and development activities in therapeutics are some major factors that are anticipated to influence seasonal affective disorder therapeutics demand over the forecast period.
Research & development activities are of paramount importance in helping create effective therapeutic solutions for seasonal affective disorders. Seasonal affective disorder therapeutic providers are focusing on expanding their research scope and creating novel therapeutic solutions for patients.
- For instance, in April 2021, researchers at the Indiana University School of Medicine published a new study that indicates promising results of blood tests to detect bipolar disorders and depression. This study, led by Dr. Alexander B. Niculescu, is expected to offer a promising scope of precision medicine and personalized treatment for patients.
Demand for seasonal affective disorder therapeutics is estimated to rise at a CAGR of 4.3% from 2022 to 2028.
What Market Factors Could Seasonal Affective Disorder Therapeutic Providers Benefit From?
“Increasing Popularity of Light Therapy to Positively Impact Market Potential”
Bright light therapy has emerged as one of the most popular aspects of the seasonal affective disorder therapeutics marketplace in recent years. This therapy provides a rapid anti-depressant effect on patients and has seen an increase in recommendation by physicians and health professionals.
- For instance, in July 2021, researchers at the University of Fribourg published a study in the PLOS Genetics journal and depicted effects of light therapy on depression in mice models. Activation of circadian clock gene Period1 in the mood-affecting region of the brain was found to help treat depression, in this study by Urs Albrecht.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat is Negatively Affecting Demand for Seasonal Affective Disorder Therapeutic Devices?
“Lack of Research Data & Adverse Effects of Anti-depressants to Majorly Hamper Market Growth”
Scarce research data and low availability of information on seasonal affective disorders are anticipated to be major barriers for seasonal affective disorder therapeutics providers. Inadequate research data on effects of bright light and blue light on the treatment of patients is expected to restrain market potential.
Adverse effects associated with excessive use of anti-depressants and other therapy drugs are predicted to be a major issue in the seasonal affective disorder therapeutics industry landscape over the forecast period.
What is the Regional Outlook for Seasonal Affective Disorder Therapeutic Companies?
“North America to Exhibit Highly Lucrative Opportunities through 2028”
Statistical analysis of seasonal affective disorder therapeutics market metrics for regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA) has been assessed in this market study.
Accounting for a dominative market share of 38.4% in the global seasonal affective disorder therapeutics marketplace, North America is anticipated to provide a highly beneficial setting for seasonal affective disorder therapeutic companies. Increasing prevalence of seasonal affective disorders and rising focus on healthcare are expected to be major trends in this region.
Second to North America, the Europe seasonal affective disorder therapeutics product market accounts for a market share of 29.5% in 2022. Increasing healthcare expenditure and rising research and development activities for seasonal affective disorders are expected to be prominent trends in this region through 2028.
Rising awareness about anxiety and depression is expected to majorly boost awareness about seasonal affective disorders in regions of East Asia and South Asia. Currently, East Asia and South Asia account for market shares of 18.5% and 7.5% in the global seasonal affective disorder therapeutics market.
Lack of awareness, low research activity, and underdeveloped healthcare infrastructure are expected to lead to slow growth in seasonal affective disorder therapeutics demand in regions of Oceania and the MEA. At present, the MEA and Oceania regions hold market shares of 1.5% and 1%, respectively, in the global seasonal affective disorder therapeutics industry.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Analysis
What is the Outlook for Seasonal Affective Disorder Therapeutic Device Manufacturers in India?
“Rising Awareness & Focus on Mental Health Expected to Positively Impact Market Expansion”
Mental health has emerged as one of the most concerning healthcare issues in India over the past few years and this has also bolstered demand for multiple seasonal affective disorder treatments. Developing healthcare infrastructure, lack of awareness, and lack of availability of treatments are expected to be prominent trends controlling demand for seasonal affective disorder therapeutics in India.
How Will the U.S. Seasonal Affective Disorder Therapeutics Market Fare?
“High Prevalence of Multiple Seasonal Affective Disorders to Positively Influence Demand”
The U.S. has seen a substantial increase in instances of anxiety and depression-related disorders and this has fostered a demand for seasonal affective disorder therapeutics. Rising instances of bipolar disorders is the major trend that drives the market potential for this nation.
High research & development activities and increasing availability of treatment options are also expected to favor seasonal affective disorder therapeutics demand.
Seasonal affective disorder therapeutic providers are focusing on developing and launching novel treatment solutions to maximize their revenue potential in the nation.
Category-wise Analysis
What Influence Does Bipolar Disorder Have on This Market?
“High Incidence of Bipolar Disorders to Majorly Govern Seasonal Affective Disorder Therapeutics Demand”
Bipolar disorder has emerged as one of the most prominent seasonal affective disorders over recent years and this has led to its substantial influence on the seasonal affective disorder therapeutics marketplace.
This disorder is expected to hold a dominant market share over the forecast period and is expected to be a majorly influential segment through 2028.
COVID-19 Impact Survey
The unexpected and sudden emergence of the COVID-19 pandemic adversely affected the mental health of people all over the globe and led to an increase in anxiety and depression in individuals.
While the seasonal affective disorder therapeutics market saw a negative growth trend in 2020 due to disruptions to supply chains and lockdown mandates, the seasonal affective disorder therapeutics market is expected to see high demand in the post-pandemic era.
Competitive Landscape
Seasonal affective disorder therapeutic providers are investing in the research & development of novel therapeutics specific to seasonal affective disorders. Seasonal affective disorder therapeutic equipment manufacturing companies are also adopting organic and inorganic strategies to increase awareness about seasonal affective disorders and boost their sales revenue.
- For instance, in December 2021, the U.S. Food and Drug Administration (FDA) cleared a new drug that would be used in treating bipolar depression. The drug Caplyta (lumateperone) created by a pharmaceutical company called Intra-Cellular Therapies, has been approved to treat depressive episodes that are resulted from bipolar I or bipolar II disorders in adults.
As it is the first FDA-approved drug of its kind, it is expected to see high demand over the coming years.
Seasonal Affective Disorder Therapeutics Industry Report Scope
|
Attribute |
Details |
|
Forecast Period |
2022-2028 |
|
Historical Data Available for |
2013-2021 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Segments of Seasonal Affective Disorder Therapeutics Industry Survey
Seasonal Affective Disorder Therapeutics Market by Treatment Type:
- Seasonal Affective Disorder Therapeutic Drugs
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)
- Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
- Monoamine Oxidase Inhibitors (MAOIs)
- Tricyclic Antidepressants (TCAs)
- Seasonal Affective Disorder Therapeutic Devices
- Light Boxes
- Dawn Stimulators
- Desk Lamps
- Sun Visors
Seasonal Affective Disorder Therapeutics Market by Disorder Type:
- Seasonal Affective Disorder Therapeutics for Unipolar Disorders
- Fall-Winter Onset
- Spring-Summer Onset
- Seasonal Affective Disorder Therapeutics for Bipolar Disorders
Seasonal Affective Disorder Therapeutics Market by Distribution Channel:
- Institutional Sales
- Seasonal Affective Disorder Therapeutics for Hospitals
- Seasonal Affective Disorder Therapeutics for Clinics
- Seasonal Affective Disorder Therapeutics for Wellness Centres & Spas
- Retail Sales
- Retail Pharmacies
- Drug Stores
- Online Sales
Seasonal Affective Disorder Therapeutics Market by Region:
- North America Seasonal Affective Disorder Therapeutics Market
- Latin America Seasonal Affective Disorder Therapeutics Market
- Europe Seasonal Affective Disorder Therapeutics Market
- East Asia Seasonal Affective Disorder Therapeutics Market
- South Asia & Pacific Seasonal Affective Disorder Therapeutics Market
- Middle East & Africa (MEA) Seasonal Affective Disorder Therapeutics Market
Frequently Asked Questions
How big is the seasonal affective disorder therapeutics market expected to be by 2028?
The global seasonal affective disorder therapeutics market is anticipated to attain a valuation of US$ 1.1 Bn by the end of 2028.
Who are the key seasonal affective disorder therapeutic product manufacturers?
Key suppliers of seasonal affective disorder therapeutic systems are F. Hoffman-La Roche AG, Mylan N.V., Sanofi AG, Novartis AG, Janssen Pharmaceuticals Inc., Koninklije Philips N.V., and The Sunbox Company.
What market share is held by North America in 2022?
Currently, the North America seasonal affective disorder therapeutics market holds a prominent share of 38.4% in the global industry.
What is the growth outlook for the forecast period?
From 2022 to 2028, the seasonal affective disorder therapeutics market is predicted to expand at a CAGR of 4.3%.
What is the seasonal affective disorder therapeutics market total in 2022?
In 2022, the seasonal affective disorder therapeutics market accounts for a value of US$ 848.2 Mn.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Macro-Economic Factors 3.2. Forecast Factors - Relevance & Impact 3.3. Market Dynamics 3.3.1. Drivers 3.3.2. Restraints 3.3.3. Opportunities 3.3.4. Trends 4. Key Success Factors 4.1. Key Regulations 4.2. Disease Epidemiology 5. Global Seasonal Affective Disorder Therapeutics Market Volume Analysis 2013-2021 and Forecast, 2022-2028 5.1. Historical Market Volume (‘000 Units) Analysis, 2013-2021 5.2. Current and Future Market Volume (‘000 Units) Projections, 2022-2028 6. Global Seasonal Affective Disorder Therapeutics Market - Pricing Analysis 6.1. Regional Pricing Analysis By Device Type 6.2. Global Average Pricing Analysis Benchmark 7. Global Seasonal Affective Disorder Therapeutics Market Value Analysis 2013-2021 and Forecast, 2022-2028 7.1. Historical Market Value (US$ Mn) Analysis, 2013-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2028 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Treatment Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013 - 2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2022 – 2022 8.3.1. Drugs 8.3.1.1. Selective serotonin reuptake inhibitors (SSRIs) 8.3.1.2. Norepinephrine-dopamine reuptake inhibitor (NDRI) 8.3.1.3. Serotonin and norepinephrine reuptake inhibitors (SNRIs) 8.3.1.4. Monoamine oxidase inhibitors (MAOIs) 8.3.1.5. Tricyclic antidepressants (TCAs) 8.3.2. Devices 8.3.2.1. Light Boxes 8.3.2.2. Dawn Stimulators 8.3.2.3. Desk Lamps 8.3.2.4. Sun Visors 8.4. Market Attractiveness Analysis By Treatment Type 9. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Disorder Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Disorder Type, 2013 - 2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disorder Type, 2022 - 2022 9.3.1. Unipolar Disorder 9.3.1.1. Fall-winter onset 9.3.1.2. Spring-summer onset 9.3.1.2. Bipolar Disorder 9.4. Market Attractiveness Analysis By Sales Channel 10. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Distribution Channel 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013 - 2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2022 10.3.1. Institutional Sales 10.3.1.1. Hospitals 10.3.1.2. Clinics 10.3.1.3. Wellness Centers & Spas 10.3.2. Retail Sales 10.3.2.1. Retail Pharmacies 10.3.2.2. Drug Stores 10.3.2.3. Online Sales 10.4. Market Attractiveness Analysis By Distribution Channel 11. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2021 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2022 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. Middle East and Africa (MEA) 11.3.5. East Asia 11.3.6. South Asia 11.3.7. Oceania 11.4. Market Attractiveness Analysis By Region 12. North America Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028 12.3.1. By Country 12.3.1.1. U.S. 12.3.1.2. Canada 12.3.2. By Treatment Type 12.3.3. By Disorder Type 12.3.4. By Distribution Channel 12.4. Market Attractiveness Analysis 13. Latin America Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Treatment Type 13.3.3. By Disorder Type 13.3.4. By Distribution Channel 13.4. Market Attractiveness Analysis 14. Europe Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. Italy 14.3.1.3. France 14.3.1.4. U.K. 14.3.1.5. Spain 14.3.1.6. Russia 14.3.1.7. Rest of Europe 14.3.2. By Treatment Type 14.3.3. By Disorder Type 14.3.4. By Distribution Channel 14.4. Market Attractiveness Analysis 15. South Asia Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Indonesia 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Treatment Type 15.3.3. By Disorder Type 15.3.4. By Distribution Channel 15.4. Market Attractiveness Analysis 16. East Asia Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By Treatment Type 16.3.3. By Disorder Type 16.3.4. By Distribution Channel 16.4. Market Attractiveness Analysis 17. Oceania Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Treatment Type 17.3.3. By Disorder Type 17.3.4. By Distribution Channel 17.4. Market Attractiveness Analysis 18. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. South Africa 18.3.1.3. Rest of Middle East and Africa 18.3.2. By Treatment Type 18.3.3. By Disorder Type 18.3.4. By Distribution Channel 18.4. Market Attractiveness Analysis 19. Emerging Countries Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028 19.1. Introduction 19.1.1. Market Value Proportion Analysis, By Key Countries 19.1.2. Global Vs. Country Growth Comparison 19.2. China Seasonal Affective Disorder Therapeutics Market Analysis 19.2.1. Introduction 19.2.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 19.2.2.1. By Treatment Type 19.2.2.2. By Disorder Type 19.2.2.3. By Distribution Channel 19.3. Russia Seasonal Affective Disorder Therapeutics Market Analysis 19.3.1. Introduction 19.3.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 19.3.2.1. By Treatment Type 19.3.2.2. By Disorder Type 19.3.2.3. By Distribution Channel 19.4. Indonesia Seasonal Affective Disorder Therapeutics Market Analysis 19.4.1. Introduction 19.4.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 19.4.2.1. By Treatment Type 19.4.2.2. By Disorder Type 19.4.2.3. By Distribution Channel 19.4.3. Russia Seasonal Affective Disorder Therapeutics Market - Competition Landscape 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Deep Dive 20.2.1. Allergan plc 20.2.1.1. Overview 20.2.1.2. Product Portfolio 20.2.1.3. Analyst Commentary 20.2.1.4. Key Financials 20.2.1.5. Strategy Overview 20.2.2. Eli Lily Company 20.2.3. GlaxoSmithKline 20.2.4. Pfizer Inc. 20.2.5. Teva Pharmaceuticals 20.2.6. Bausch Health Companies Inc. 20.2.7. F. Hoffmann-La Roche AG 20.2.8. Mylan N.V. 20.2.8.1. Sanofi AG 20.2.9. Novartis AG 20.2.10. Janssen Pharmaceuticals, Inc. 20.2.11. Koninklijke Philips N.V 20.2.12. The Sunbox Company 20.2.13. Beurer GmbH 20.2.14. Lucimed S.A. 21. Assumptions and Acronyms Used 22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Treatment Type Table 02: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Treatment Type Table 03: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Disorder Type Table 04: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Distribution Channel Table 05: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Region Table 06: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country Table 07: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type Table 08: North America Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type Table 09: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type Table 10: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel Table 11: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country Table 12: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type Table 13: Latin America Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type Table 14: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type Table 15: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel Table 16: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country Table 17: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type Table 18: Europe Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type Table 19: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type Table 20: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel Table 21: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country Table 22: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type Table 23: South Asia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type Table 24: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type Table 25: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel Table 26: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country Table 27: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type Table 28: East Asia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type Table 29: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type Table 30: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel Table 31: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country Table 32: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type Table 33: Oceania Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type Table 34: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type Table 35: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel Table 36: MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country Table 37: Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type Table 38: MEA Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type Table 39: MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type Table 40: MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel Table 41: China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type Table 42: China Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type Table 43: China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type Table 44: China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel Table 45: Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type Table 46: Russia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type Table 47: Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type Table 48: Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel Table 49: Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type Table 50: Indonesia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type Table 51: Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type Table 52: Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Seasonal Affective Disorder Therapeutics Market Volume Analysis (‘000 Units), By Devices, 2013-2017 Figure 02: Global Seasonal Affective Disorder Therapeutics Market Volume Forecast (‘000 Units), By Devices, 2018-2028 Figure 03: Light Boxes, Pricing Analysis per unit (US$), By Region, 2017 Figure 04: Light Boxes, Pricing Analysis per unit (US$), By Region, 2028 Figure 05: Dawn Stimulator, Pricing Analysis per unit (US$), By Region, 2017 Figure 06: Dawn Stimulator, Pricing Analysis per unit (US$), By Region, 2028 Figure 07: Desk Lamp, Pricing Analysis per unit (US$), By Region, 2017 Figure 08: Desk Lamp, Pricing Analysis per unit (US$), By Region, 2028 Figure 09: Sun Visors , Pricing Analysis per unit (US$), By Region, 2017 Figure 10: Sun Visors , Pricing Analysis per unit (US$), By Region, 2028 Figure 11: Global Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017 Figure 12: Global Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028 Figure 13: Global Seasonal Affective Disorder Therapeutics Market Absolute $ Opportunity, 2018 - 2028 Figure 14: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Treatment Type, 2018 & 2028 Figure 15: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Treatment Type, 2018-2028 Figure 16: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028 Figure 17: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Disorder Type, 2018 & 2028 Figure 18: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Disorder Type, 2018-2028 Figure 19: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028 Figure 20: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Distribution Channel, 2018 & 2028 Figure 21: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Distribution Channel, 2018-2028 Figure 22: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028 Figure 23: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Region, 2018 & 2028 Figure 24: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Region, 2018-2028 Figure 25: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Region, 2018-2028 Figure 26: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E) Figure 27: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E) Figure 28: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E) Figure 29: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E) Figure 30: North America Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017 Figure 31: North America Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028 Figure 32: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028 Figure 33: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028 Figure 34: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028 Figure 35: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028 Figure 36: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E) Figure 37: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E) Figure 38: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E) Figure 39: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E) Figure 40: Latin America Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017 Figure 41: Latin America Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028 Figure 42: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028 Figure 43: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028 Figure 44: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028 Figure 45: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028 Figure 46: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E) Figure 47: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E) Figure 48: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E) Figure 49: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E) Figure 50: Europe Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017 Figure 51: Europe Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028 Figure 52: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028 Figure 53: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028 Figure 54: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028 Figure 55: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028 Figure 56: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E) Figure 57: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E) Figure 58: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E) Figure 59: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E) Figure 60: South Asia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017 Figure 61: South Asia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028 Figure 62: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028 Figure 63: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028 Figure 64: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028 Figure 65: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028 Figure 66: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E) Figure 67: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E) Figure 68: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E) Figure 69: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E) Figure 70: East Asia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017 Figure 71: East Asia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028 Figure 72: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028 Figure 73: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028 Figure 74: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028 Figure 75: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028 Figure 76: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E) Figure 77: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E) Figure 78: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E) Figure 79: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E) Figure 80: Oceania Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017 Figure 81: Oceania Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028 Figure 82: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028 Figure 83: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028 Figure 84: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028 Figure 85: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028 Figure 86: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E) Figure 87: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E) Figure 88: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E) Figure 89: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E) Figure 90: MEA Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017 Figure 91: MEA Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028 Figure 92: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028 Figure 93: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028 Figure 94: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028 Figure 95: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028 Figure 96: Global Seasonal Affective Disorder Therapeutics Market Value Proportion Analysis, By Emerging Countries, 2018 Figure 97: Seasonal Affective Disorder Therapeutics Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2018-2028 Figure 98: China Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017 Figure 99: China Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028 Figure 100: Russia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017 Figure 101: Russia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028 Figure 102: Indonesia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017 Figure 103: Indonesia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
